SCHEMBL7745327

SCHEMBL7745327

[CH2]SC(=S)NC1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 2/20 0.52
TP53 P04637 1/20 0.52
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
MAPK1 P28482 1/20 0.43
DUSP3 P51452 1/20 0.43
PTPN5 P54829 1/20 0.43
PTPN11 Q06124 1/20 0.43
EPHX1 P07099 5/20 0.41
MAPT P10636 1/20 0.41
KDM4E B2RXH2 1/20 0.41
EPHX2 P34913 1/20 0.41
HTT P42858 1/20 0.38
POLB P06746 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3072017 0.78 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL3078929 0.78 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL7745330 0.76 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL27759933 0.71 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL3062295 0.71 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL3061955 0.70 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL3082353 0.70 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL14405489 0.70 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL491492 0.69 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL3075946 0.69 ALDH1A1 (0.70) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001040244-A1 N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES CV THERAPEUTICS, INC. (US) 2001-06-07 WO claimed
WO-2001040244-A1 N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES CV THERAPEUTICS, INC. (US) 2001-06-07 WO disclosed